Synthesis and biological activity of α-l-fucosyl ceramides, analogues of the potent agonist, α-d-galactosyl ceramide KRN7000

Natacha Veerapen, Faye Reddington, Gabriel Bricard, Steven A. Porcelli, Gurdyal S. Besra

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Several l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of iNKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. α-Galactosyl ceramide (α-GalCer) is a known agonist of iNKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of α-l-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the α-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely α-selective, and could be scaled up to provide gram quantities of the azide precursor 11, from which a range of N-acylated α-l-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human iNKT cells.

Original languageEnglish (US)
Pages (from-to)3223-3226
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number11
DOIs
StatePublished - Jun 1 2010

Fingerprint

Galactosylceramides
Natural Killer T-Cells
Ceramides
Bioactivity
Azides
Iodides
Cystic Fibrosis
Rheumatoid Arthritis
Chemical activation
Cytokines
Derivatives
Molecules
KRN 7000
Neoplasms

Keywords

  • Antigen
  • CD1d
  • Ceramide
  • iNKT
  • Lipid

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Synthesis and biological activity of α-l-fucosyl ceramides, analogues of the potent agonist, α-d-galactosyl ceramide KRN7000. / Veerapen, Natacha; Reddington, Faye; Bricard, Gabriel; Porcelli, Steven A.; Besra, Gurdyal S.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 20, No. 11, 01.06.2010, p. 3223-3226.

Research output: Contribution to journalArticle

@article{38567c904a5b48349eac9cd0483d8b82,
title = "Synthesis and biological activity of α-l-fucosyl ceramides, analogues of the potent agonist, α-d-galactosyl ceramide KRN7000",
abstract = "Several l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of iNKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. α-Galactosyl ceramide (α-GalCer) is a known agonist of iNKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of α-l-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the α-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely α-selective, and could be scaled up to provide gram quantities of the azide precursor 11, from which a range of N-acylated α-l-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human iNKT cells.",
keywords = "Antigen, CD1d, Ceramide, iNKT, Lipid",
author = "Natacha Veerapen and Faye Reddington and Gabriel Bricard and Porcelli, {Steven A.} and Besra, {Gurdyal S.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.bmcl.2010.04.079",
language = "English (US)",
volume = "20",
pages = "3223--3226",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Synthesis and biological activity of α-l-fucosyl ceramides, analogues of the potent agonist, α-d-galactosyl ceramide KRN7000

AU - Veerapen, Natacha

AU - Reddington, Faye

AU - Bricard, Gabriel

AU - Porcelli, Steven A.

AU - Besra, Gurdyal S.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Several l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of iNKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. α-Galactosyl ceramide (α-GalCer) is a known agonist of iNKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of α-l-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the α-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely α-selective, and could be scaled up to provide gram quantities of the azide precursor 11, from which a range of N-acylated α-l-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human iNKT cells.

AB - Several l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of iNKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. α-Galactosyl ceramide (α-GalCer) is a known agonist of iNKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of α-l-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the α-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely α-selective, and could be scaled up to provide gram quantities of the azide precursor 11, from which a range of N-acylated α-l-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human iNKT cells.

KW - Antigen

KW - CD1d

KW - Ceramide

KW - iNKT

KW - Lipid

UR - http://www.scopus.com/inward/record.url?scp=77953292181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953292181&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2010.04.079

DO - 10.1016/j.bmcl.2010.04.079

M3 - Article

C2 - 20462758

AN - SCOPUS:77953292181

VL - 20

SP - 3223

EP - 3226

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 11

ER -